OS Therapies, Inc. (NYSE-A: OSTX) (“OS Therapies” or “the Company”), a clinical-stage cancer immunotherapy and antibody drug conjugate biotechnology c ...
If the framework survives the Trump administration, it could provide transparency into self-driving vehicles—and could help consumers grow more accustomed to them.